Deutsch English Français

Contact

EP1429843

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1429843

EP1429843 - COMBINATION OF A PDE INHIBITOR AND A LEUKOTRIENE RECEPTOR ANTAGONIST [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 02.11.2007 Database last updated on 16.07.2024
Most recent event Tooltip	02.11.2007	No opposition filed within time limit	published on 05.12.2007 [2007/49]
Applicant(s)	For all designated states Nycomed GmbH Byk-Gulden-Strasse 2 78467 Konstanz / DE
	[2007/32]
Former [2004/26]	For all designated states ALTANA Pharma AG Byk-Gulden-Strasse 2 78467 Konstanz / DE
Inventor(s)	01 / BEUME, Rolf Bohlstrasse 13 78465 Konstanz / DE
	02 / BUNDSCHUH, Daniela Im Rank 5 CH - 8272 Ermatingen / CH
	03 / WEIMAR, Christian Helene und Maria Schiessstr.29 78467 Konstanz / DE
	04 / WOLLIN, Stefan-Lutz Lehrenweg 15/4 88709 Meersburg / DE
	[2007/18]
Former [2006/52]	01 / BEUME, Rolf Bohlstrasse 13 78465 Konstanz / DE
	02 / * * *
	03 / WEIMAR, Christian Helene und Maria Schiessstr.29 78467 Konstanz / DE
	04 / WOLLIN, Stefan-Lutz Lehrenweg 15/4 88709 Meersburg / DE
Former [2006/48]	01 / BEUME, Rolf Bohlstrasse 13 78465 Konstanz / DE
	02 / BUNDSCHUH, Daniela Rheingutstrasse 17 78462 Konstanz / DE
	03 / WEIMAR, Christian Helene und Maria Schiessstr.29 78467 Konstanz / DE
	04 / WOLLIN, Stefan-Lutz Lehrenweg 15/4 88709 Meersburg / DE
Former [2004/26]	01 / BEUME, Rolf Bohlstrasse 13 78465 Konstanz / DE
	02 / BUNDSCHUH, Daniela Rheingutstrasse 17 78462 Konstanz / DE
	03 / WEIMAR, Christian Eichhornstr. 51 78464 Konstanz / DE
	04 / WOLLIN, Stefan-Lutz Lehrenweg 15/4 88709 Meersburg / DE
Representative(s)	Wild, Robert Takeda GmbH Postfach 10 03 10 78403 Konstanz / DE
	[N/P]
Former [2004/26]	Wild, Robert c/o ALTANA Pharma AG, Byk-Gulden-Strasse 2 78467 Konstanz / DE
Application number, filing date	02798730.4	17.09.2002
	[2004/26]
	WO2002EP10423
Priority number, date	EP20010000474	19.09.2001 Original published format: EP 01000474
	[2004/26]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO03024488
	Date:	27.03.2003
	Language:	EN
	[2003/13]
	Type:	A2 Application without search report
	No.:	EP1429843
	Date:	23.06.2004
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 27.03.2003 takes the place of the publication of the European patent application.
	[2004/26]
	Type:	B1 Patent specification
	No.:	EP1429843
	Date:	27.12.2006
	Language:	EN
	[2006/52]
Search report(s)	International search report - published on:	EP	04.09.2003
Classification	IPC:	A61P11/06, A61K31/47, A61K31/44, A61K45/06	[2006/23]
	CPC:	A61K45/06 (EP,US); A61K31/47 (KR); A61P11/00 (EP); A61P11/06 (EP)
	Former IPC [2004/26]	A61P11/06
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2004/26]
Extension states	AL	19.04.2004
	LT	19.04.2004
	LV	19.04.2004
	MK	19.04.2004
	RO	19.04.2004
	SI	19.04.2004
Title	German:	KOMBINATION VON EINEM PDE-HEMMER UND EINES LEUKOTRIEN REZEPTOR ANTAGONISTEN	[2004/26]
	English:	COMBINATION OF A PDE INHIBITOR AND A LEUKOTRIENE RECEPTOR ANTAGONIST	[2004/26]
	French:	COMBINAISON D'UN INHIBITEUR DE PDE ET D'UN ANTAGONISTE DU RECEPTEUR DE LEUKOTRIENE	[2006/23]
	Former [2004/26]	NOUVELLE COMBINAISON
Entry into regional phase	19.04.2004	National basic fee paid
	19.04.2004	Designation fee(s) paid
	19.04.2004	Examination fee paid
Examination procedure	08.04.2003	Request for preliminary examination filed International Preliminary Examining Authority: EP
	19.04.2004	Examination requested [2004/26]
	23.06.2005	Despatch of a communication from the examining division (Time limit: M06)
	10.02.2006	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	04.04.2006	Reply to a communication from the examining division
	06.06.2006	Communication of intention to grant the patent
	16.10.2006	Fee for grant paid
	16.10.2006	Fee for publishing/printing paid
Opposition(s)	28.09.2007	No opposition filed within time limit [2007/49]
Request for further processing for:	04.04.2006	Request for further processing filed
	04.04.2006	Full payment received (date of receipt of payment) Request granted
	21.04.2006	Decision despatched
Fees paid	Renewal fee
	14.09.2004	Renewal fee patent year 03
	14.09.2005	Renewal fee patent year 04
	11.09.2006	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XY]WO0050011 (SMITHKLINE BEECHAM CORP [US], et al) [X] 1-3,9-12,18-20,25,26 * page 1, lines 8-10; claims 1-3,6 * * page 4, line 33 - page 5, line 11 * * page 5, lines 12-29 * [Y] 1-26;
		[Y]WO0113953 (BYK GULDEN LOMBERG CHEM FAB [DE], et al) [Y] 1-6,9-15,18-22,25,26 * page 20, line 4, paragraph 2; example .; claims 1-6,12 * * page 16, paragraph 3 *;
		[X]WO0146151 (MERCK FROSST CANADA INC [CA], et al) [X] 1-3,9-12,18-20,25,26 * page 32, lines 15-17; claims 20,21 *;
		[XY]WO0157036 (PFIZER PROD INC [US], et al) [X] 1,4,5,8-11,13,14,17-19,21,24-26 * claims 13,15 * [Y] 1-26;
		[PX]WO0170738 (MERCK FROSST CANADA INC [CA], et al) [PX] 1,9,11,18,19,25,26 * page 3, lines 7-13; claims 18-22 * * page 16, lines 2-4 *;
		[PX]WO0190076 (MERCK FROSST CANADA INC [CA], et al) [PX] 1,9,11,18,19,25,26 * page 3, lines 15-22; claims 1,3-7 * * page 16, lines 4-6 *;
		[XY] - KRAWIEC, MARZENA E. ET AL, "Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma", EXPERT OPINION ON PHARMACOTHERAPY (2001), 2(1), 47-65, XP008002079 [X] 1-26 * page 57; figure 1 * [Y] 1-26 DOI: http://dx.doi.org/10.1517/14656566.2.1.47
		[PX] - CAMPILLO N. ET AL, "Novel bronchodilators in the treatment of asthma and COPD.", EXPERT OPINION ON THERAPEUTIC PATENTS, (2002) 12/1 (53-63)., XP008002080 [PX] 1-26 * pages 58-60 * DOI: http://dx.doi.org/10.1517/13543776.12.1.53

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p